Cut-throat competition weighs down small-sized manufacturers

Many small- and medium-sized pharmaceutical firms find it much harder to increase their revenues amid fierce competition in domestic generic drug market.

The top 30 pharmaceutical firms, which are relatively rich in cash, are speeding up further market expansions with aggressive marketing assaults in hospitals and clinic sector.

Big pharmaceutical firms plan to reach a 1-trillion-won visi...